Literature DB >> 6969152

Lymphocyte subpopulations in non-neoplastic thymus from myasthenia gravis patients.

M Piantelli, P Musiani, L Lauriola, A Carbone, P Tonali, M A Dina.   

Abstract

Lymphocyte populations in non-neoplastic thymuses from fifteen patients with myasthenia gravis (MG) were examined. As in normal subjects, the great majority of thymic lymphocytes of MG patients are T cells. When MG thymuses were compared to normal glands, lower percentages of lymphocytes able to form E rosettes resistant to incubation at 37 degrees C (stable E rosettes) were found in MG thymuses. A negligible B cell content was detected in eight normal and in eight MG thymuses with absent or rare lymph follicles; but there was a substantial B cell presence in the thymuses of seven MG cases with thymic hyperplasia containing many germinal centres. Normal and MG thymuses contain the same percentage of lymphocytes bearing receptors for the Fc portion of IgM (TM). Moreover, the IgM Fc receptor was found mostly on cells which did not form stable E rosettes and did not bear surface immunoglobulin. The possible significance of these findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6969152      PMCID: PMC1536911     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Letter: B lymphocytes in the thymus of patients with myasthenia gravis.

Authors:  F G Staber; U Fink; W Sack
Journal:  N Engl J Med       Date:  1975-05-08       Impact factor: 91.245

2.  Aspects of lymphocyte function in myasthenia gravis.

Authors:  R P Lisak; N I Abdou; B Zweiman; C Zmijewski; A S Penn
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

3.  The thymus in myasthenia gravis. Evidence for altered cell populations.

Authors:  N I Abdou; R P Lisak; B Zweiman; I Abrahamsohn; A S Penn
Journal:  N Engl J Med       Date:  1974-12-12       Impact factor: 91.245

4.  Rheumatic diseases in patients with myasthenia gravis. An epidemiological and clinical investigation.

Authors:  H J Oosterhuis; W H de Haas
Journal:  Acta Neurol Scand       Date:  1968       Impact factor: 3.209

Review 5.  Myasthenia as an autoimmune disease: clinical aspects.

Authors:  S M Wolf; L P Rowland; D L Schotland; A S McKinney; P F Hoefer; H Aranow
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

Review 6.  Serum acetylcholine-receptor antibodies in myasthenia gravis.

Authors:  R R Almon; S H Appel
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

7.  Subpopulations of human thymus cells differing in their capacity to form stable E-rosettes and in their immunologic reactivity.

Authors:  U Galili; M Schlesinger
Journal:  J Immunol       Date:  1975-09       Impact factor: 5.422

Review 8.  The role of humoral and cellular immune factors in neuromuscular block in myasthenia gravis.

Authors:  T Namba; Y Nakata; D Grob
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

9.  Experimental autoimmune myasthenia gravis and myasthenia gravis: biochemical and immunochemical aspects.

Authors:  J M Lindstrom; V A Lennon; M E Seybold; S Whittingham
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

Review 10.  Studies on the nature of autoimmunity in myasthenia gravis. Evidence for an immunodeficiency type.

Authors:  J A Simpson; P O Behan; H M Dick
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

View more
  1 in total

Review 1.  Phenotypic and functional analysis of lymphocytes in myasthenia gravis.

Authors:  A I Levinson; R P Lisak; B Zweiman; M Kornstein
Journal:  Springer Semin Immunopathol       Date:  1985
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.